DEDICATION
TRUTH-SEEKING
DARE TO BE THE FIRST IN THE WORLD
Learn more →
DEDICATION
TRUTH-SEEKING
DARE TO BE THE FIRST IN THE WORLD
Learn more →
DEDICATION
TRUTH-SEEKING
DARE TO BE THE FIRST IN THE WORLD
Learn more →
scroll down

Get to know Gaitianli

Committed to solving the worldwide problems in the treatment of tumors and immune diseases


Established in June 1995, Qidong Gaitianli Medicines Co., Ltd. is a modern Chinese medicine company specializing in the research and development, manufacturing and sales of proprietary Chinese medicine solid preparations. The plant covers an area of more than 130,000 square meters, the production construction area of more than 100,000 square meters, with a complete set of research and development, cultivation, extraction, granulation and testing in one of the modern production line, the annual production capacity of 9500 tons of huaier fungus and 250 million bags of granule, the company's net assets of more than 500 million yuan, the existing staff of more than 1700 people.

Since its establishment more than 20 years ago, the company has believed in the enterprise development strategy of "concentration, concentration and clustering".......

Learn more →

Strong R & D 

capability

GAITIANLI
1995 Year

Company establishment


500 million

Total assets of company


1700 +

The number of employees


Products

Committed to the development of tumor tissue analysis technology, instruments and reagents, to provide new solutions for the precise diagnosis and personalized treatment of tumors.

Huaier Granules

Huaier is a natural fungus that grows on ancient Chinese sophora trees. It was first recorded as a medicinal ingredient in ancient Chinese medical texts such as Zhou Hou Fang (a collection of prescriptions for emergency treatments) and Tang Ben Cao (an herbal book from the Tang Dynasty). Huaier has a bitter and pungent taste, is neutral in nature and non-toxic, and believed to have the effects of "dispelling wind", "breaking up blood stasis," and "enhancing vitality.”

Learn more →

Huaiqihuang (HQH) Granule

HQH Granule possesses both anti-inflammatory properties and bidirectional immune regulation, effectively ensuring immune balance within the body.

Learn more →

Overview of Ongoing Research Projects

TitleLeading InstitutePrincipal InvestigatorNumber of Participating CentersNumber of CasesResearch Status
Not yet recruitedRecruiting in progressDuring follow-upAt the end of the question
Study on Huaier Granules in Unresectable Hepatocellular Carcinoma at Stage III According to the CNLC Staging System
Multicenter, Registry Study to Observe the Efficacy and Safety of Different Treatment Regimens for Unresectable Hepatocellular Carcinoma at Stage III According to the CNLC Staging System
Zhongshan Hospital, Fudan University Fan Jia 22 750
Study on Huaier Granules Versus Capecitabine Monotherapy in Preventing Recurrence and Metastasis after Radical Surgery for Stage II Colorectal Cancer
Prospective, Multicenter, Randomized, Parallel-Controlled Study on Huaier Granules Versus Capecitabine Monotherapy in Preventing Recurrence and Metastasis after Radical Surgery for Stage II Colorectal Cancer
Fudan University Shanghai Cancer Center Cai Sanjun 23 756
Clinical Study on Prednisone Combined with Huaiqihuang Granules in the Treatment of Nephrotic Syndrome in Children
Prospective, Multicenter, Randomized, Double-Blind, Double-Dummy, Non-Inferiority Parallel-Controlled Clinical Trial to Compare the Efficacy and Safety of Prednisone Combined with Huaiqihuang Granules Versus Prednisone Combined with Levamisole in the Treatment of Nephrotic Syndrome in Children
Tongji Hospital of Tongji Medical College of HUST Zhou Jianhua 25 402
Study on Huaiqihuang (HQH) Granules in the Treatment of Primary Glomerulonephritis at Stage 3 CKD
Randomized, Double-Blind, Double-Dummy, Positive Parallel-Controlled Multicenter Clinical Study on Huaiqihuang (HQH) Granules in the Treatment of Primary Glomerulonephritis at Stage 3 CKD
The First Affiliated Hospital of Dalian Medical University Lin Hongli 35 466
Study on Huaier Granules in the Treatment of Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
Multicenter, Randomized, Open, Parallel-Controlled Clinical Study on Huaier Granules in the Treatment of Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
Chinese PLA General Hospital Chen Xiangmei 30 480
Observational Study on Huaier Granules in Patients with Advanced Breast Cancer without Visceral Metastasis
Multicenter, Open, Randomized Controlled, Prospective Clinical Study on Huaier Granules in Patients with Advanced Breast Cancer without Visceral Metastasis
Fudan University Shanghai Cancer Center Shao Zhimin 8 398

Understanding Gaitian Power

Creating value for human health and well-being

News Center

Time to share with you dynamic

In order to further meet the clinical needs, our company has changed the auxiliary materials in Huaiqihuang granules (replacing sucrose and soluble starch with maltodextrin). At the same time, the packaging form of Huai Qi Huang granules has also been changed for the convenience of carrying.

2023

11.28

Foreign patients and couples looking for doctors to buy Huaier granules

Foreign patients and couples looking for doctors to buy Huaier granules
On November 24, 2023, Mr. Poetsch, a Stephan from Switzerland, and Ms. Ann Makphon, his wife, traveled thousands of miles to China to find a doctor and buy Huaier granules.

2023

03.02

Huaier granules for new packaging!

Huaier granules for new packaging!
From February 15, 2023, the new packaging and new specifications of Huaier granules will be sent to various places one after another. The changed packaging specifications changed from 20 grams per bag to 10 grams per bag, reducing the amount of excipients, especially the removal of sucrose, which is more conducive to diabetic patients.

2022

06.27

Information Publicity on Qidong Gaitianli Pharmaceutical Co., Ltd. to Carry out Cleaner Production Audit in 2022

Information Publicity on Qidong Gaitianli Pharmaceutical Co., Ltd. to Carry out Cleaner Production Audit in 2022
According to Nantong Ecological Environment Bureau's Notice on Doing a Good Job in Cleaner Production Audit in 2022 (Tonghua Office (2022) No.16), Qidong Gaitianli Pharmaceutical Co., Ltd. will carry out cleaner production audit in 2022.